Chemomab Therapeutics (CMMB)
(Delayed Data from NSDQ)
$1.07 USD
+0.01 (0.93%)
Updated May 31, 2024 03:59 PM ET
After-Market: $1.01 -0.06 (-5.60%) 4:34 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.20 | 0.00% |
Earnings Summary
For their last quarter, Chemomab Therapeutics (CMMB) reported earnings of -$0.28 per share, missing the Zacks Consensus Estimate of -$0.20 per share. This reflects a negative earnings surprise of 40.00%. Look out for CMMB's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 72.22%.
Earnings History
Price & Consensus
Zacks News for CMMB
Here's Why Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Is a Great 'Buy the Bottom' Stock Now
CMMB: What are Zacks experts saying now?
Zacks Private Portfolio Services